Literature DB >> 18838107

Comparison of inhibitory potency of three different curcuminoid pigments on nitric oxide and tumor necrosis factor production of rat primary microglia induced by lipopolysaccharide.

Li Jia Zhang1, Chun Fu Wu, Xue Lian Meng, Dan Yuan, Xu Dong Cai, Qi Long Wang, Jing Yu Yang.   

Abstract

Microglia are the resident innate immune cells in the central nervous system. Evidence supports that the unregulated activation of microglia results in the production of pro-inflammatory cytokines and chemokines that propagate neuronal injury and finally cause neurodegenerative diseases. Curcuminn (Cur), demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC) are curcuminoid pigments extracted from turmeric (Curcuma longa L.). Cur has been reported to suppress the activation of microglia by reducing toxic factors production, but little is known about whether the two natural demethoxy derivatives of Cur, DMC and BDMC, have the similar effects as Cur. In the present study, we found that all of the three curcuminoid pigments significantly suppressed nitric oxide (NO) production by LPS-activated microglia and the relative potency was DMC>BDMC>Cur. This result was verified by RT-PCR analysis of iNOS mRNA. The NO-scavenging abilities of three curcuminoid pigments are very weak, which suggested that the indirect effect may not be critical in inhibiting NO production by LPS-activated microglia. Moreover, these three curcuminoid pigments attenuated the expression of mRNA and proteins of tumor necrosis factor-alpha (TNF-alpha) in a concentration-dependent manner and the relative potency was also DMC>BDMC>Cur. In conclusion, Cur, DMC and BDMC were found as potent microglia-activation inhibitors, and DMC exhibited the strongest inhibitory activity on NO and TNF-alpha production. These results provided an interesting clue for designing new compounds which could have better potential therapeutic implications for various neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838107     DOI: 10.1016/j.neulet.2008.09.067

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention.

Authors:  Komal Shahani; Suresh Kumar Swaminathan; Diana Freeman; Angela Blum; Linan Ma; Jayanth Panyam
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

2.  Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Authors:  Rudra P Ojha; Manisha Rastogi; B Parimala Devi; Aruna Agrawal; G P Dubey
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-21       Impact factor: 4.147

Review 3.  Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives - A review.

Authors:  Augustine Amalraj; Anitha Pius; Sreerag Gopi; Sreeraj Gopi
Journal:  J Tradit Complement Med       Date:  2016-06-15

4.  Curcuminoid analogs inhibit nitric oxide production from LPS-activated microglial cells.

Authors:  Jiraporn Tocharus; Sataporn Jamsuwan; Chainarong Tocharus; Chatchawan Changtam; Apichart Suksamrarn
Journal:  J Nat Med       Date:  2011-10-13       Impact factor: 2.343

5.  Bisdemethoxycurcumin-mediated Attenuation of Apoptosis Prevents Gentamicin-induced Ototoxicity in Mouse Cochlear UB/OC-2 Cells.

Authors:  Ting-Ya Kang; Chuan-Jen Hsu; Jia-Ni Lin; Chen-Chi Wu; Jen-Shu Wang; Hui-Yi Lin; Szu-Hui Yu; Rong-Shuan Wu; Yu-Hsuan Wen; Guo-Fang Tseng; Hung-Pin Wu
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

Review 6.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  Bioavailability of a Sustained Release Formulation of Curcumin.

Authors:  Doddabele Madhavi; Daniel Kagan
Journal:  Integr Med (Encinitas)       Date:  2014-06

8.  Barrier protective activities of curcumin and its derivative.

Authors:  Dong-Chan Kim; Sae-Kwang Ku; Wonhwa Lee; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2012-01-12       Impact factor: 4.575

9.  Demethoxycurcumin Promotes Macrophage Cell Population and Phagocytosis in WEHI-3 Cell-generated Leukemia BALB/c Mice In Vivo.

Authors:  Yi-Jia Lin; Chiung-Ju Chen; Shu-Ching Hsueh; Mei-Hui Lee; Shu-Fen Peng; Hsu-Feng Lu; Kung-Wen Lu; Wen-Wen Huang; Kuo-Ching Liu; Yung-Liang Chen; Yung-Luen Shih; Jin-Cherng Lien
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

10.  The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells.

Authors:  Xuesen Yang; Genlin He; Yutong Hao; Chunhai Chen; Maoquan Li; Yuan Wang; Guangbin Zhang; Zhengping Yu
Journal:  J Neuroinflammation       Date:  2010-09-09       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.